- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-33-0022167

Chinar Therapeutics Private Limited
About Chinar Therapeutics Private Limited
Data last updated:
Chinar Therapeutics Private Limited is a private limited company based in Udaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U74999RJ2017PTC058432. Its GSTIN is 08AAHCC0748F1ZS (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Naresh Sharma and Swati Sharma.
Its last annual general meeting (AGM) was held on 20 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Udaipur, Rajasthan.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.94 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹21.52 Lakh (net margin 3.1%) and EBITDA of ₹46.36 Lakh (EBITDA margin 6.7%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 20% over five years.
The company has about 46 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹66 Lakh and satisfied charges of ₹58.05 Lakh on record.
Chinar Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-33-0022167). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Chinar Therapeutics
Contact details
Chinar Therapeutics Private Limited's registered office is in Udaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. B – 176, South Extension Scheme Balicha, Udaipur, Rajasthan, India – 313001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Chinar Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Chinar Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Chinar Therapeutics Private Limited, buy the company report.
Financials of Chinar Therapeutics Private Limited
FY 2025 filings availableChinar Therapeutics Private Limited reported revenue of ₹6.94 Cr (up 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 36% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹46.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.52 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.7% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Chinar Therapeutics Private Limited, buy the company report.
Board of directors of Chinar Therapeutics Private Limited
Chinar Therapeutics has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Sharma Also directs: Shree Satyam Imaging LLP, Shantiraj Hospital Private Limited | Director | 28 Jun 2017 | 9 Years 4 Months | Current |
| Swati Sharma | Director | 28 Jun 2017 | 9 Years 4 Months | Current |
| Grijesh Agal | Director | 22 Apr 2025 | 1 Years 6 Months | Current |
Peer comparison
Chinar Therapeutics Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aakar Fragrance Limited | ₹6.97 Cr (FY 2025) | 5.0% | Ahmedabad, Gujarat, India | |||
| Sukesh Industries Private Limited | ₹6.97 Cr (FY 2025) | 28.0% | Jaipur, Rajasthan, India | |||
| M M Arochem Private Limited | ₹6.96 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Clean Engineering Private Limited | ₹6.96 Cr (FY 2025) | -11.0% | Badlapur East, Maharashtra, India | |||
| Gujarat Life Sciences Private Limited | ₹6.94 Cr (FY 2025) | -15.0% | Vadodara, Gujarat, India | |||
| Chinar Therapeutics Private Limitedthis company | ₹6.94 Cr (FY 2025) | ₹21.52 Lakh | 3.1% | 36.0% | 46 | Udaipur, Rajasthan, India |
| Himgiri Metals Private Limited | ₹6.94 Cr (FY 2025) | 56.0% | Muzaffarnagar, Uttar Pradesh, India | |||
| Vulcan Laboratories Pvt Ltd | ₹6.93 Cr (FY 2025) | 24.0% | Kolkata, West Bengal, India | |||
| Riswana Polymers India Private Limited | ₹6.93 Cr (FY 2025) | 226.0% | Sriperumbudur, Tamil Nadu, India | |||
| Medinovation Vision Private Limited | ₹6.93 Cr (FY 2024) | Mumbai, Maharashtra, India | ||||
| Spab Chemicals Private Limited | ₹6.93 Cr (FY 2024) | 26.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Chinar Therapeutics Private Limited, buy the company report.
Auditor
Chinar Therapeutics Private Limited is audited by GARG & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GARG & ASSOCIATES | FY 2023 | 0000185C |
Shareholding
The shareholding of Chinar Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Chinar Therapeutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Mar 2024 | 100933844 | Others | ₹16.5 Lakh | Open | |
| 31 Mar 2024 | 100933831 | Others | ₹49.5 Lakh | Open | |
| 07 Dec 2022 | 100651158 | Yes Bank Limited | ₹50 Lakh | Satisfied | |
| 21 Oct 2021 | 100496522 | Hdfc Bank Limited | ₹8.05 Lakh | Satisfied |
To see the full charge records of Chinar Therapeutics Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Chinar Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Chinar Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Chinar Therapeutics Private Limited has a workforce of 46 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 46 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Chinar Therapeutics Private Limited, buy the company report.
GST
Chinar Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAHCC0748F1ZS | Rajasthan | Active | 18 Sep 2018 |
To see the full GST registrations and return filing status of Chinar Therapeutics Private Limited, buy the company report.
Recent activity
Chinar Therapeutics Private Limited has 5 board changes on record since 2017: 3 appointments and 2 cessations. The latest: Grijesh Agal ceased to be Additional Director on 19 Sep 2025.
4 earlier events are in the company report.
Frequently asked questions
Chinar Therapeutics is an active private limited company based in Udaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 June 2017 (9+ years old) and is registered under CIN U74999RJ2017PTC058432.
Chinar Therapeutics has 3 current directors:
- Naresh Sharma - Director
- Swati Sharma - Director
- Grijesh Agal - Director
The latest financial statements of Chinar Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 20 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Chinar Therapeutics is 08AAHCC0748F1ZS, registered in Rajasthan.
The CIN (Corporate Identification Number) of Chinar Therapeutics is U74999RJ2017PTC058432. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chinar Therapeutics was incorporated on 28 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Chinar Therapeutics by revenue are Aakar Fragrance Limited, Sukesh Industries Private Limited, M M Arochem Private Limited, Clean Engineering Private Limited, Gujarat Life Sciences Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Grijesh Agal ceased to be Additional Director on 19 Sep 2025. Grijesh Agal was appointed as Director on 22 Apr 2025. Swati Sharma ceased to be Director on 22 Apr 2025. Chinar Therapeutics has 5 board changes on record in total.
Yes, Chinar Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-33-0022167).
The registered office of Chinar Therapeutics is at Plot No. B – 176, South Extension Scheme Balicha, Udaipur, Rajasthan, India – 313001.
Chinar Therapeutics operates in the pharma industry, in the drug formulation and development segment.

